- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 5.87M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 5.16M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 612.82K sh |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.35M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $2.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $43.52M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $43.96M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.26M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $8.21M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.37M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $9.33M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $49.51M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $50.76M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $51.89M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $53.29M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.25 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$7.55 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.25 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$7.48 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.28M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$4.57M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.32M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$30.64M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $73.2K |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $71.03K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $139.41K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $471.11K |
| Revenue | Q1 2026 · Mar 31, 2026 | $212.61K |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $542.13K |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $1.42K |